160 related articles for article (PubMed ID: 38757478)
1. Kinetically Inert Platinum (II) Complexes for Improving Anticancer Therapy: Recent Developments and Road Ahead.
Panda TR; Patra M
ChemMedChem; 2024 May; ():e202400196. PubMed ID: 38757478
[TBL] [Abstract][Full Text] [Related]
2. The Power of Kinetic Inertness in Improving Platinum Anticancer Therapy by Circumventing Resistance and Ameliorating Nephrotoxicity.
Panda TR; M M; Vaidya SP; Chhatar S; Sinha S; Mehrotra M; Chakraborty S; Gadre S; Duari P; Ray P; Patra M
Angew Chem Int Ed Engl; 2023 Sep; 62(38):e202303958. PubMed ID: 37314332
[TBL] [Abstract][Full Text] [Related]
3. Improving In Vivo Tumor Accumulation and Efficacy of Platinum Antitumor Agents by Electronic Tuning of the Kinetic Lability.
M M; Chhatar S; Gadre S; Paul S; Vaidya SP; Khatri S; Duari P; Kode J; Ingle A; Kolthur-Seetharam U; Patra M
Chemistry; 2024 Jan; 30(4):e202302720. PubMed ID: 37888749
[TBL] [Abstract][Full Text] [Related]
4. [Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].
Komeda S
Yakugaku Zasshi; 2012; 132(3):253-9. PubMed ID: 22382827
[TBL] [Abstract][Full Text] [Related]
5. Platinum(IV) Carboxylate Prodrug Complexes as Versatile Platforms for Targeted Chemotherapy.
Ong JX; Yap SQ; Wong DY; Chin CF; Ang WH
Chimia (Aarau); 2015; 69(3):100-3. PubMed ID: 26507211
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the Inertness to Hydrolysis of Platinum(IV) Prodrugs.
Ritacco I; Mazzone G; Russo N; Sicilia E
Inorg Chem; 2016 Feb; 55(4):1580-6. PubMed ID: 26812023
[TBL] [Abstract][Full Text] [Related]
7. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.
Johnstone TC; Suntharalingam K; Lippard SJ
Chem Rev; 2016 Mar; 116(5):3436-86. PubMed ID: 26865551
[TBL] [Abstract][Full Text] [Related]
8. Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity.
Aher S; Zhu J; Bhagat P; Borse L; Liu X
Top Curr Chem (Cham); 2024 Feb; 382(1):6. PubMed ID: 38400859
[TBL] [Abstract][Full Text] [Related]
9. Beyond mere DNA damage: Recent progress in platinum(IV) anticancer complexes containing multi-functional axial ligands.
Deng Z; Zhu G
Curr Opin Chem Biol; 2023 Jun; 74():102303. PubMed ID: 37075513
[TBL] [Abstract][Full Text] [Related]
10. Anticancer Activity, Reduction Mechanism and G-Quadruplex DNA Binding of a Redox-Activated Platinum(IV)-Salphen Complex.
Vigna V; Scoditti S; Spinello A; Mazzone G; Sicilia E
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555221
[TBL] [Abstract][Full Text] [Related]
11. Oxidation of the Platinum(II) Anticancer Agent [Pt{(
Ojha R; Junk PC; Bond AM; Deacon GB
Molecules; 2023 Sep; 28(17):. PubMed ID: 37687231
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic
Acharya S; Maji M; Chakraborty MP; Bhattacharya I; Das R; Gupta A; Mukherjee A
Inorg Chem; 2021 Mar; 60(5):3418-3430. PubMed ID: 33554592
[TBL] [Abstract][Full Text] [Related]
13. Monofunctional Platinum(II) Anticancer Agents.
Jin S; Guo Y; Guo Z; Wang X
Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33562293
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antiproliferative activity in cancer cells and DNA interaction studies of [Pt(cis-1,3-diaminocycloalkane)Cl
Hoeschele JD; Kasparkova J; Kostrhunova H; Novakova O; Pracharova J; Pineau P; Brabec V
J Biol Inorg Chem; 2020 Sep; 25(6):913-924. PubMed ID: 32851480
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Characterization and Antiproliferative Evaluation of Pt(II) and Pd(II) Complexes with a Thiazine-Pyridine Derivative Ligand.
Gutiérrez-Tarriño S; Espino J; Luna-Giles F; Rodríguez AB; Pariente JA; Viñuelas-Zahínos E
Pharmaceuticals (Basel); 2021 Apr; 14(5):. PubMed ID: 33921955
[TBL] [Abstract][Full Text] [Related]
16. Binding of kinetically inert metal ions to RNA: the case of platinum(II).
Chapman EG; Hostetter AA; Osborn MF; Miller AL; DeRose VJ
Met Ions Life Sci; 2011; 9():347-77. PubMed ID: 22010278
[TBL] [Abstract][Full Text] [Related]
17. Photoactivatable platinum complexes.
Bednarski PJ; Mackay FS; Sadler PJ
Anticancer Agents Med Chem; 2007 Jan; 7(1):75-93. PubMed ID: 17266506
[TBL] [Abstract][Full Text] [Related]
18. A Dogma in Doubt: Hydrolysis of Equatorial Ligands of Pt
Kastner A; Poetsch I; Mayr J; Burda JV; Roller A; Heffeter P; Keppler BK; Kowol CR
Angew Chem Int Ed Engl; 2019 May; 58(22):7464-7469. PubMed ID: 30870571
[TBL] [Abstract][Full Text] [Related]
19. From Basics of Coordination Chemistry to Understanding Cisplatin-analogue Pt Drugs.
Akitsu T; Tsvetkova D; Yamamoto Y; Nakane D; Kostova I
Curr Pharm Des; 2023; 29(22):1747-1774. PubMed ID: 37559240
[TBL] [Abstract][Full Text] [Related]
20. The Platin-X series: activation, targeting, and delivery.
Basu U; Banik B; Wen R; Pathak RK; Dhar S
Dalton Trans; 2016 Aug; 45(33):12992-3004. PubMed ID: 27493131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
